Tag Archive for USANA

Award-Winning Leadership: USANA’s Chief Scientific Officer Honored with Women Tech Award

Dr. Kathryn Armstrong, USANA chief scientific officer, named a “Leadership Excellence Award” winner
USANA (NYSE:USNA) is proud to announce that its chief scientific officer, Dr. Kathryn Armstrong, has received the Women Tech Award from the Women Tech Council of Utah.
The Women Tech Award is a distinguished recognition platform that celebrates women who are significantly contributing to the expansion and innovation within the technology sector. The program aims to enhance the visibility of women who are not only advancing technology but also inspiring the broader community. This award underscores USANA‘s commitment to scientific innovation and visionary leadership.
Learn more about USANA’s scientific innovation and award-winning products at USANA.com.

“I am incredibly honored to be recognized by the Women Tech Council of Utah along with the other inspiring winners,”

said Dr. Kathryn Armstrong.

“This award is a testament to our amazing team of scientific professionals at USANA. We are dedicated to pushing the boundaries of science and innovation to create the highest quality nutritional products for our Brand Partners and customers.
“This award is not just a personal achievement; it is a reflection of USANA’s unwavering commitment to empowering women in the workplace and its drive for innovation,”

continues Dr. Armstrong.

“I am proud to be part of a

Read more...

USANA Wins 2025 Good Housekeeping Beauty Award

USANA Celavive Postbiotic Rescue Serum Wins Good Housekeeping Beauty Award For 2025.
USANA Health Sciences, Inc., (NYSE:USNA) a global leader in cellular nutrition, announced today that its Celavive Postbiotic Rescue Serum was named as a winner in Good Housekeeping’s 2025 Beauty Awards.
The full list of awards can be found on the Good Housekeeping Beauty Awards 2025.
To learn more about USANA and the science behind its products, please visit USANA.com.
Brent Neidig, USANA’s chief commercial officer, shared:
“We’re so excited that our Postbiotic Rescue Serum has been named a Good Housekeeping 2025 Beauty Award winner. Our product and R&D teams have put so much time and effort into creating our postbiotic line and this incredible award goes to them for all their hard work.”
USANA Celavive’s Postbiotic Rescue Serum is a calming daily serum that helps to visibly reset and balance the appearance of stressed-out, blemish-prone skin. Its lightweight formula features microbiome-friendly postbiotics and soothing botanicals to improve the look of stressed skin and help replenish moisture.
About USANA
USANA prides itself on providing consumers with quality nutritional and lifestyle products. From its award-winning supplements to its innovative Celavive skincare and Active Nutrition lines, USANA has proven for over 30 years why it’s a company you can trust.
The post USANA

Read more...

USANA Q1 Revenue Up 10% To $250 Million

First Quarter 2025 vs. First Quarter 2024:

Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency.

“USANA is off to a solid start to the year as we continue to execute our growth strategy through our core direct sales business and our recently acquired direct-to-consumer business, Hiya. We are seeing encouraging signs in our direct sales business with net sales and Active Customers growing modestly on a sequential basis for the second consecutive quarter,”

said Jim Brown, President and Chief Executive Officer.

“Hiya delivered strong growth in net sales and Active Monthly Subscribers. Hiya’s momentum remains strong and should continue building as their team executes their plans to launch several new products this year, unveil another strategic partnership, and expand to additional channels.
We continue to be confident in the growth trajectory of this business that is reaching a new customer demographic for us. On a consolidated basis, constant currency net sales grew 12% year-over-year and we are reiterating our full-year outlook.
While the global macroeconomic environment has become less certain since the beginning of the year due to volatility in international trade, tariffs, and consumer sentiment, the underlying demand for our products has remained

Read more...

USANA Appoints New Chief Scientific Officer

USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company.
Kathryn has served as USANA’s executive vice president of research and development since July of 2024.  Kathryn’s predecessor, Dr. Rob Sinnott, announced his retirement at the end of 2024, but will continue to assist in the company’s pursuit for scientific excellence as its senior scientific fellow.
Kathryn joins USANA with 17 years of experience working for some of the most recognizable corporations in the world. She graduated from Loyola University Chicago with a B.S. in Chemistry and earned her Ph.D. in Biochemistry from the University of Notre Dame.
She began her professional career in 2007 at Whirlpool as a senior engineer with the Advanced Chemical Process Team and worked her way to lead engineer with the Technology and Chemical Process Group. Kathryn then joined BISSELL Homecare, Inc. in 2010 as their associate director of product attributes. Most recently, Kathryn spent nearly nine years at Amway in different roles, including as vice president of new ventures, sciences, plant, agriculture, and systems.
Jim Brown, CEO and president of USANA said:

“I am very excited to have Dr. Armstrong serve as our

Read more...

USANA Named Top Manufacturer

USANA Health Sciences, Inc. received the award for the Manufacturer of the Year by the Utah Manufacturers Association in the “mega-sized (500+ employees) companies” category. This is the third consecutive year that USANA has been recognized with this honor.

“USANA has a mission to manufacture high-quality products, and because we take pride in our manufacturing practices, we create products people trust,” said Walter Noot, USANA Chief Operating Officer.
“We are one of the few companies to manufacture almost 70% of our products in our state-of-the-art, FDA-registered facility (excluding Mainland China), something I am truly proud of. USANA is committed to excellence—and being named manufacturer of the year for a third year in a row proves that.”

USANA is committed to manufacturing its supplements, foods, powders and select skincare products on-site. Two of its high-speed tablet presses can produce between 60,000 to 500,000 nutritional supplement tablets an hour, while maintaining strict quality attributes.

“Our manufacturing capabilities are one of our biggest differentiators as a company,” said Jim Brown, USANA CEO and President.
“Our ability to manufacture the majority of our products in-house while maintaining extremely high Good Manufacturing Practices (GMP) standards is a major selling point for our distributors, and a reason why we

Read more...

USANA Q2 Revenue 11% Down To $213 Million

USANA Health Sciences, Inc.announced financial results for its fiscal second quarter ended June 29, 2024.
Key Financial & Operating Results

Second quarter net sales were $213 million versus $238 million during Q2 2023.
Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023.
Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 million and $2.40 to $3.00).

“Second quarter operating results were below our expectations,”

said Jim Brown, President and Chief Executive Officer.

“Ongoing macroeconomic pressures in several of our key markets continue to impact consumer spending. This in turn creates challenges in our ability to attract and engage new customers and generate sales momentum.
To counter these challenges, we have made several strategic changes in our business over the past few quarters, including (i) restructuring our commercial team, (ii) heightening our focus on product innovation, (iii) increasing our efforts to engage our sales leaders with an Associate-first approach, (iv) expanding into India, and (v) evaluating more business development activities.
“Next month, we will be hosting our Americas & Europe Convention in Las Vegas, Nevada along with other Associate engagement-focused events in the back half of the

Read more...

USA Q2 Revenue 2024 Down 11% To $ 213 Million

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024.
Key Financial & Operating Results

Second quarter net sales were $213 million versus $238 million during Q2 2023.
Second quarter diluted EPS was $0.54 as compared with $0.89 during Q2 2023.
Company updates fiscal year 2024 net sales and diluted EPS outlook to $850 million to $880 million and $2.40 to $2.55 (previously $850 million to $920 million and $2.40 to $3.00).

“Second quarter operating results were below our expectations,”

said Jim Brown, President and Chief Executive Officer.

“Ongoing macroeconomic pressures in several of our key markets continue to impact consumer spending. This in turn creates challenges in our ability to attract and engage new customers and generate sales momentum.
To counter these challenges, we have made several strategic changes in our business over the past few quarters, including (i) restructuring our commercial team, (ii) heightening our focus on product innovation, (iii) increasing our efforts to engage our sales leaders with an Associate-first approach, (iv) expanding into India, and (v) evaluating more business development activities.
“Next month, we will be hosting our Americas & Europe Convention in Las Vegas, Nevada along with other Associate engagement-focused events in the back half of the year. We are also planning to offer a more robust promotional calendar throughout the remainder of the year.”

Balance Sheet and Share Repurchase Activity
The Company generated $8 million in operating

Read more...

USANA Executives Make First Visit To New India Market

CEO Jim Brown visits the country to meet the local team, leaders, and share long-term vision for the market.
Reaching one million active customers is the first step towards USANA Health Sciences, Inc.’s mission of building the healthiest family on earth—making international expansion a critical initiative.
In late 2023, USANA opened its business to the India market, and for the first time since that opening, USANA’s President and CEO Jim Brown will be visiting the country. Mr. Brown will be accompanied by USANA’s Chief Sales Officer David Mulham and Vice President of Market Expansion & Ethics Dan Whitney.
The group will tour the company’s office in Gurgaon and meet with the local team that boasts more than 100 years of combined industry expertise. The visiting executives will then present USANA’s vision and long-term commitment to the India market in front of the strong, emerging, and progressive members of the USANA India family.
Jim Brow said:

“I am very much looking forward to my first visit to our India market and to meeting our amazing USANA India members. We spent many years preparing to open this strategically important market, and we believe USANA is well-aligned with India’s emphasis on family, wellness, and entrepreneurialism.
Growing USANA in one

Read more...

284 USANA-Sponsored Athletes In 2024 Summer Olympic Games In France

USANA Health Sciences, Inc. wishes the very best for the 284 sponsored USANA Athletes who earned their spot at the 2024 Summer Olympic and Paralympic Games in Paris. These athletes represent 10 nations including Canada, China, France, Indonesia, Italy, Mexico, Malaysia, South Korea, Spain, and the United States.

“USANA has been the go-to nutritional supplier for countless Olympic athletes for more than a decade. We are so excited to see our USANA Athletes go for Gold,”

said Brent Neidig, USANA’s chief commercial officer.

“No matter the outcome, we are proud of every athlete who has put their faith in USANA and our products to help their Olympic journey. All of us here at USANA are behind them all the way—we can’t wait to watch them compete.”

USANA partners with both individual athletes and national sporting organizations / teams.*
Summer Olympic Teams and Organizations Partnered with USANA:

Mexico Olympic Soccer Team, 22 athletes
USA Swimming, 46 athletes
USA Wrestling, 16 athletes
China National Sports Training Center, 182 athletes
Artistic Swimming, 9 athletes
Athletics, 56 athletes
Badminton, 16 athletes
Basketball, 16 athletes
Diving, 10 athletes
Gymnastics, 17 athletes
Swimming, 31 athletes
Table Tennis, 8 athletes
Volleyball, 13 athletes
Weightlifting, 6 athletes

Individual USANA Athletes:

Alex Portal—Para Swimming, France
Azzahra Permatahani—Swimming, Indonesia
Brooks Curry—Swimming, USA
Cheah Liek Hou—Para Badminton, Malaysia
Eduardo Lorrio—Water Polo, Spain
Jendi Pangabean—Para Swimming, Indonesia
Jeon

Read more...

USANA Q1 Revenue 2024 Down 8% To $228 Million

Key Financial & Operating Results

First quarter net sales were $228 million versus $248 million during Q1 2023, and increased 2% sequentially in constant currency.
First quarter diluted EPS was $0.86 as compared with $0.95 during Q1 2023.
Company reiterates fiscal year 2024 net sales and diluted EPS outlook of $850 million to $920 million and $2.40 to $3.00.

“Our top line results during the first quarter were driven by a successful sales incentive in mainland China, which helped counter the seasonal slowdown that we experience during the Lunar New Year holiday,”

said Jim Brown, President and Chief Executive Officer.

“This sales incentive helped us generate 15% year-over-year active customer growth in our largest market, as well as year-over-year and sequential quarter sales growth. Notwithstanding our solid performance in China, our first quarter results in other key markets did not meet internal expectations and we are actively working to accelerate our business in these markets during 2024.

Doug Hekking, Chief Financial Officer said:

“Strength in our mainland China operations carried our first quarter results. This performance helped offset softness in many other markets where we continue to face a challenging operating environment highlighted by ongoing inflationary pressures. We remain committed to engaging with Associate leaders throughout each

Read more...